Henan Genuine Biotech
Privately held: no public share price
Assets
(4 total)
4Total Assets
0Approved
1Phase 3 / Filed
3Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Azvudine(FNC) | Phase 3 | HIV reverse transcriptaseSmall molecule | HIVCOVID-19 |
| Phase 2 | HIV reverse transcriptaseSmall molecule | HIV | |
| Phase 1/2 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | Undisclosed / early pipelineSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Financial reports
No financial reports recorded.